More than half of new clinical trials are expected to use electronic data capture technology this year, says Martin Young, VP for corporate development at Phase Forward. He notes in a Life Science Leader roundtable discussion that the Internet's "decoupling of EDC from hardware" is a big factor in the technology's acceptance.
And its purpose, according to Andrew Schachter, president and CEO at Axiom, is to facilitate real-time clinical research. Access to tools that show trial status and metrics are essential to the real-time transactional data required.
Among EDC systems, best-of-breed solutions have bested single-source systems, in part because in most cases the systems have multiple users, says Patrick Hughes, senior VP at GxP Consulting.
- here's the article